サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1432085

視神経脊髄炎スペクトラム障害（NMOSD）の世界市場に関する洞察、2030年までの予測

Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Insights, Forecast to 2030
出版日: | 発行: QYResearch | ページ情報: 英文 105 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
視神経脊髄炎スペクトラム障害（NMOSD）の世界市場に関する洞察、2030年までの予測
出版日: 2024年02月26日
発行: QYResearch
ページ情報: 英文 105 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、視神経脊髄炎スペクトラム障害（NMOSD） (Neuromyelitis Optica Spectrum Disorders (NMOSD)) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析：タイプ別
    • 世界の視神経脊髄炎スペクトラム障害（NMOSD）の市場規模成長率：タイプ別, 2019 VS 2023 VS 2030
    • Relapsing Form
    • Monophasic Form
  • 市場：用途別
    • 世界の視神経脊髄炎スペクトラム障害（NMOSD）の市場規模成長率：用途別, 2019 VS 2023 VS 2030
    • Hospital
    • Clinic
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界の視神経脊髄炎スペクトラム障害（NMOSD）の市場展望 (2019-2030)
  • 世界の視神経脊髄炎スペクトラム障害（NMOSD）の市場成長トレンド：地域別
    • 視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：地域別: 2019 VS 2023 VS 2030
    • 視神経脊髄炎スペクトラム障害（NMOSD）の市場規模実績：地域別 (2019-2024)
    • 視神経脊髄炎スペクトラム障害（NMOSD）の市場規模予測：地域別 (2025-2030)
  • 視神経脊髄炎スペクトラム障害（NMOSD） 市場動向
    • 視神経脊髄炎スペクトラム障害（NMOSD） 業界動向
    • 視神経脊髄炎スペクトラム障害（NMOSD） 市場の促進要因
    • 視神経脊髄炎スペクトラム障害（NMOSD） 市場の課題
    • 視神経脊髄炎スペクトラム障害（NMOSD） 市場の抑制要因

第3章 競合情勢：主要企業別

  • 世界規模の売上高 視神経脊髄炎スペクトラム障害（NMOSD） ：競合別
    • 世界の視神経脊髄炎スペクトラム障害（NMOSD）の収益：企業別 (2019-2024)
    • 世界の視神経脊髄炎スペクトラム障害（NMOSD）の収益シェア：企業別 (2019-2024)
  • 世界の視神経脊髄炎スペクトラム障害（NMOSD）の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要企業 視神経脊髄炎スペクトラム障害（NMOSD）, 売上高ランキング, 2022 VS 2023 VS 2024
  • 世界の視神経脊髄炎スペクトラム障害（NMOSD） 市場集中度
    • 世界の視神経脊髄炎スペクトラム障害（NMOSD） 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業： 視神経脊髄炎スペクトラム障害（NMOSD）の収益 2023
  • 世界の主要企業 視神経脊髄炎スペクトラム障害（NMOSD） 本社 および提供地域
  • 世界の主要企業 視神経脊髄炎スペクトラム障害（NMOSD）, 製品およびアプリケーション
  • 世界の主要企業 視神経脊髄炎スペクトラム障害（NMOSD）, 業界参入時期
  • M&A, 拡張計画

第4章 視神経脊髄炎スペクトラム障害（NMOSD） 内訳データ：タイプ別

  • 世界の視神経脊髄炎スペクトラム障害（NMOSD）の市場規模実績：タイプ別 (2019-2024)
  • 世界の視神経脊髄炎スペクトラム障害（NMOSD）の市場規模予測：タイプ別 (2025-2030)

第5章 視神経脊髄炎スペクトラム障害（NMOSD） 内訳データ：用途別

  • 世界の視神経脊髄炎スペクトラム障害（NMOSD）の市場規模実績：用途別 (2019-2024)
  • 世界の視神経脊髄炎スペクトラム障害（NMOSD）の市場規模予測：用途別 (2025-2030)

第6章 北米

  • 北米の視神経脊髄炎スペクトラム障害（NMOSD） 市場規模 (2019-2030)
  • 北米の視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：タイプ別
    • 北米の視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：タイプ別 (2019-2024)
    • 北米の視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：タイプ別 (2025-2030)
    • 北米の視神経脊髄炎スペクトラム障害（NMOSD）の市場シェア：タイプ別 (2019-2030)
  • 北米の視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：用途別
    • 北米の視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：用途別 (2019-2024)
    • 北米の視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：用途別 (2025-2030)
    • 北米の視神経脊髄炎スペクトラム障害（NMOSD）の市場シェア：用途別 (2019-2030)
  • 北米の視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：国別
    • 北米の視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：国別: 2019 VS 2023 VS 2030
    • 北米の視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：国別 (2019-2024)
    • 北米の視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：国別 (2025-2030)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の視神経脊髄炎スペクトラム障害（NMOSD） 市場規模 (2019-2030)
  • 欧州の視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：タイプ別
    • 欧州の視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：タイプ別 (2019-2024)
    • 欧州の視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：タイプ別 (2025-2030)
    • 欧州の視神経脊髄炎スペクトラム障害（NMOSD）の市場シェア：タイプ別 (2019-2030)
  • 欧州の視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：用途別
    • 欧州の視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：用途別 (2019-2024)
    • 欧州の視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：用途別 (2025-2030)
    • 欧州の視神経脊髄炎スペクトラム障害（NMOSD）の市場シェア：用途別 (2019-2030)
  • 欧州の視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：国別
    • 欧州の視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：国別: 2019 VS 2023 VS 2030
    • 欧州の視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：国別 (2019-2024)
    • 欧州の視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：国別 (2025-2030)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 中国

  • 中国の視神経脊髄炎スペクトラム障害（NMOSD） 市場規模 (2019-2030)
  • 中国の視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：タイプ別
    • 中国の視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：タイプ別 (2019-2024)
    • 中国の視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：タイプ別 (2025-2030)
    • 中国の視神経脊髄炎スペクトラム障害（NMOSD）の市場シェア：タイプ別 (2019-2030)
  • 中国の視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：用途別
    • 中国の視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：用途別 (2019-2024)
    • 中国の視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：用途別 (2025-2030)
    • 中国の視神経脊髄炎スペクトラム障害（NMOSD）の市場シェア：用途別 (2019-2030)

第9章 アジア（中国を除く）

  • アジア地域 視神経脊髄炎スペクトラム障害（NMOSD） 市場規模 (2019-2030)
  • アジア地域 視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：タイプ別
    • アジア地域 視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：タイプ別 (2019-2024)
    • アジア地域 視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：タイプ別 (2025-2030)
    • アジア地域 視神経脊髄炎スペクトラム障害（NMOSD）の市場シェア：タイプ別 (2019-2030)
  • アジア地域 視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：用途別
    • アジア地域 視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：用途別 (2019-2024)
    • アジア地域 視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：用途別 (2025-2030)
    • アジア地域 視神経脊髄炎スペクトラム障害（NMOSD）の市場シェア：用途別 (2019-2030)
  • アジア地域 視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：地域別
    • アジア地域 視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：地域別: 2019 VS 2023 VS 2030
    • アジア地域 視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：地域別 (2019-2024)
    • アジア地域 視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：地域別 (2025-2030)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド
    • オーストラリア

第10章 中近東・アフリカ・中南米

  • 中近東・アフリカ・中南米 視神経脊髄炎スペクトラム障害（NMOSD） 市場規模 (2019-2030)
  • 中近東・アフリカ・中南米 視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：タイプ別
    • 中近東・アフリカ・中南米 視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：タイプ別 (2019-2024)
    • 中近東・アフリカ・中南米 視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：タイプ別 (2025-2030)
    • 中近東・アフリカ・中南米 視神経脊髄炎スペクトラム障害（NMOSD）の市場シェア：タイプ別 (2019-2030)
  • 中近東・アフリカ・中南米 視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：用途別
    • 中近東・アフリカ・中南米 視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：用途別 (2019-2024)
    • 中近東・アフリカ・中南米 視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：用途別 (2025-2030)
    • 中近東・アフリカ・中南米 視神経脊髄炎スペクトラム障害（NMOSD）の市場シェア：用途別 (2019-2030)
  • 中近東・アフリカ・中南米 視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：国別
    • 中近東・アフリカ・中南米 視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：国別: 2019 VS 2023 VS 2030
    • 中近東・アフリカ・中南米 視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：国別 (2019-2024)
    • 中近東・アフリカ・中南米 視神経脊髄炎スペクトラム障害（NMOSD） 市場規模：国別 (2025-2030)
    • ブラジル
    • メキシコ
    • トルコ
    • サウジアラビア
    • イスラエル
    • 湾岸協力理事会諸国

第11章 主要企業のプロファイル

  • Roche
  • Pfizer
  • Fresenius
  • Teva
  • Sandoz
  • Intas
  • Nang Kuang Pharmaceutical
  • Tianjin King York
  • Baxter
  • CSL
  • Grifols
  • Octapharma

第12章 アナリストによる分析/結論

第13章 付録

図表

List of Tables

  • Table 1. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
  • Table 2. Key Players of Relapsing Form
  • Table 3. Key Players of Monophasic Form
  • Table 4. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
  • Table 5. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
  • Table 6. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Region (2019-2024) & (US$ Million)
  • Table 7. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Share by Region (2019-2024)
  • Table 8. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecasted Market Size by Region (2025-2030) & (US$ Million)
  • Table 9. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Share by Region (2025-2030)
  • Table 10. Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Trends
  • Table 11. Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Drivers
  • Table 12. Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Challenges
  • Table 13. Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Restraints
  • Table 14. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue by Players (2019-2024) & (US$ Million)
  • Table 15. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue Share by Players (2019-2024)
  • Table 16. Global Top Neuromyelitis Optica Spectrum Disorders (NMOSD) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuromyelitis Optica Spectrum Disorders (NMOSD) as of 2023)
  • Table 17. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Industry Ranking 2022 VS 2023 VS 2024
  • Table 18. Global 5 Largest Players Market Share by Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue (CR5 and HHI) & (2019-2024)
  • Table 19. Global Key Players of Neuromyelitis Optica Spectrum Disorders (NMOSD), Headquarters and Area Served
  • Table 20. Global Key Players of Neuromyelitis Optica Spectrum Disorders (NMOSD), Product and Application
  • Table 21. Global Key Players of Neuromyelitis Optica Spectrum Disorders (NMOSD), Product and Application
  • Table 22. Mergers & Acquisitions, Expansion Plans
  • Table 23. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2019-2024) & (US$ Million)
  • Table 24. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue Market Share by Type (2019-2024)
  • Table 25. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecasted Market Size by Type (2025-2030) & (US$ Million)
  • Table 26. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue Market Share by Type (2025-2030)
  • Table 27. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2019-2024) & (US$ Million)
  • Table 28. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue Share by Application (2019-2024)
  • Table 29. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecasted Market Size by Application (2025-2030) & (US$ Million)
  • Table 30. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue Share by Application (2025-2030)
  • Table 31. North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2019-2024) & (US$ Million)
  • Table 32. North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2025-2030) & (US$ Million)
  • Table 33. North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2019-2024) & (US$ Million)
  • Table 34. North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2025-2030) & (US$ Million)
  • Table 35. North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
  • Table 36. North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Country (2019-2024) & (US$ Million)
  • Table 37. North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Country (2025-2030) & (US$ Million)
  • Table 38. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2019-2024) & (US$ Million)
  • Table 39. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2025-2030) & (US$ Million)
  • Table 40. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2019-2024) & (US$ Million)
  • Table 41. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2025-2030) & (US$ Million)
  • Table 42. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
  • Table 43. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Country (2019-2024) & (US$ Million)
  • Table 44. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Country (2025-2030) & (US$ Million)
  • Table 45. China Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2019-2024) & (US$ Million)
  • Table 46. China Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2025-2030) & (US$ Million)
  • Table 47. China Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2019-2024) & (US$ Million)
  • Table 48. China Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2025-2030) & (US$ Million)
  • Table 49. Asia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2019-2024) & (US$ Million)
  • Table 50. Asia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2025-2030) & (US$ Million)
  • Table 51. Asia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2019-2024) & (US$ Million)
  • Table 52. Asia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2025-2030) & (US$ Million)
  • Table 53. Asia Neuromyelitis Optica Spectrum Disorders (NMOSD) Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
  • Table 54. Asia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Region (2019-2024) & (US$ Million)
  • Table 55. Asia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Region (2025-2030) & (US$ Million)
  • Table 56. Middle East, Africa, and Latin America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2019-2024) & (US$ Million)
  • Table 57. Middle East, Africa, and Latin America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2025-2030) & (US$ Million)
  • Table 58. Middle East, Africa, and Latin America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2019-2024) & (US$ Million)
  • Table 59. Middle East, Africa, and Latin America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2025-2030) & (US$ Million)
  • Table 60. Middle East, Africa, and Latin America Neuromyelitis Optica Spectrum Disorders (NMOSD) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
  • Table 61. Middle East, Africa, and Latin America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Country (2019-2024) & (US$ Million)
  • Table 62. Middle East, Africa, and Latin America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Country (2025-2030) & (US$ Million)
  • Table 63. Roche Company Details
  • Table 64. Roche Business Overview
  • Table 65. Roche Neuromyelitis Optica Spectrum Disorders (NMOSD) Product
  • Table 66. Roche Revenue in Neuromyelitis Optica Spectrum Disorders (NMOSD) Business (2019-2024) & (US$ Million)
  • Table 67. Roche Recent Developments
  • Table 68. Pfizer Company Details
  • Table 69. Pfizer Business Overview
  • Table 70. Pfizer Neuromyelitis Optica Spectrum Disorders (NMOSD) Product
  • Table 71. Pfizer Revenue in Neuromyelitis Optica Spectrum Disorders (NMOSD) Business (2019-2024) & (US$ Million)
  • Table 72. Pfizer Recent Developments
  • Table 73. Fresenius Company Details
  • Table 74. Fresenius Business Overview
  • Table 75. Fresenius Neuromyelitis Optica Spectrum Disorders (NMOSD) Product
  • Table 76. Fresenius Revenue in Neuromyelitis Optica Spectrum Disorders (NMOSD) Business (2019-2024) & (US$ Million)
  • Table 77. Fresenius Recent Developments
  • Table 78. Teva Company Details
  • Table 79. Teva Business Overview
  • Table 80. Teva Neuromyelitis Optica Spectrum Disorders (NMOSD) Product
  • Table 81. Teva Revenue in Neuromyelitis Optica Spectrum Disorders (NMOSD) Business (2019-2024) & (US$ Million)
  • Table 82. Teva Recent Developments
  • Table 83. Sandoz Company Details
  • Table 84. Sandoz Business Overview
  • Table 85. Sandoz Neuromyelitis Optica Spectrum Disorders (NMOSD) Product
  • Table 86. Sandoz Revenue in Neuromyelitis Optica Spectrum Disorders (NMOSD) Business (2019-2024) & (US$ Million)
  • Table 87. Sandoz Recent Developments
  • Table 88. Intas Company Details
  • Table 89. Intas Business Overview
  • Table 90. Intas Neuromyelitis Optica Spectrum Disorders (NMOSD) Product
  • Table 91. Intas Revenue in Neuromyelitis Optica Spectrum Disorders (NMOSD) Business (2019-2024) & (US$ Million)
  • Table 92. Intas Recent Developments
  • Table 93. Nang Kuang Pharmaceutical Company Details
  • Table 94. Nang Kuang Pharmaceutical Business Overview
  • Table 95. Nang Kuang Pharmaceutical Neuromyelitis Optica Spectrum Disorders (NMOSD) Product
  • Table 96. Nang Kuang Pharmaceutical Revenue in Neuromyelitis Optica Spectrum Disorders (NMOSD) Business (2019-2024) & (US$ Million)
  • Table 97. Nang Kuang Pharmaceutical Recent Developments
  • Table 98. Tianjin King York Company Details
  • Table 99. Tianjin King York Business Overview
  • Table 100. Tianjin King York Neuromyelitis Optica Spectrum Disorders (NMOSD) Product
  • Table 101. Tianjin King York Revenue in Neuromyelitis Optica Spectrum Disorders (NMOSD) Business (2019-2024) & (US$ Million)
  • Table 102. Tianjin King York Recent Developments
  • Table 103. Baxter Company Details
  • Table 104. Baxter Business Overview
  • Table 105. Baxter Neuromyelitis Optica Spectrum Disorders (NMOSD) Product
  • Table 106. Baxter Revenue in Neuromyelitis Optica Spectrum Disorders (NMOSD) Business (2019-2024) & (US$ Million)
  • Table 107. Baxter Recent Developments
  • Table 108. CSL Company Details
  • Table 109. CSL Business Overview
  • Table 110. CSL Neuromyelitis Optica Spectrum Disorders (NMOSD) Product
  • Table 111. CSL Revenue in Neuromyelitis Optica Spectrum Disorders (NMOSD) Business (2019-2024) & (US$ Million)
  • Table 112. CSL Recent Developments
  • Table 113. Grifols Company Details
  • Table 114. Grifols Business Overview
  • Table 115. Grifols Neuromyelitis Optica Spectrum Disorders (NMOSD) Product
  • Table 116. Grifols Revenue in Neuromyelitis Optica Spectrum Disorders (NMOSD) Business (2019-2024) & (US$ Million)
  • Table 117. Grifols Recent Developments
  • Table 118. Octapharma Company Details
  • Table 119. Octapharma Business Overview
  • Table 120. Octapharma Neuromyelitis Optica Spectrum Disorders (NMOSD) Product
  • Table 121. Octapharma Revenue in Neuromyelitis Optica Spectrum Disorders (NMOSD) Business (2019-2024) & (US$ Million)
  • Table 122. Octapharma Recent Developments
  • Table 123. Research Programs/Design for This Report
  • Table 124. Key Data Information from Secondary Sources
  • Table 125. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
  • Figure 2. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Share by Type: 2023 VS 2030
  • Figure 3. Relapsing Form Features
  • Figure 4. Monophasic Form Features
  • Figure 5. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
  • Figure 6. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Share by Application: 2023 VS 2030
  • Figure 7. Hospital Case Studies
  • Figure 8. Clinic Case Studies
  • Figure 9. Neuromyelitis Optica Spectrum Disorders (NMOSD) Report Years Considered
  • Figure 10. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size (US$ Million), Year-over-Year: 2019-2030
  • Figure 11. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size, (US$ Million), 2019 VS 2023 VS 2030
  • Figure 12. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Share by Region: 2023 VS 2030
  • Figure 13. Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Share by Players in 2023
  • Figure 14. Global Top Neuromyelitis Optica Spectrum Disorders (NMOSD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuromyelitis Optica Spectrum Disorders (NMOSD) as of 2023)
  • Figure 15. The Top 10 and 5 Players Market Share by Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue in 2023
  • Figure 16. North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 17. North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Share by Type (2019-2030)
  • Figure 18. North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Share by Application (2019-2030)
  • Figure 19. North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Share by Country (2019-2030)
  • Figure 20. United States Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 21. Canada Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 22. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size YoY (2019-2030) & (US$ Million)
  • Figure 23. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Share by Type (2019-2030)
  • Figure 24. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Share by Application (2019-2030)
  • Figure 25. Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Share by Country (2019-2030)
  • Figure 26. Germany Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 27. France Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 28. U.K. Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 29. Italy Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 30. Russia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 31. Nordic Countries Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 32. China Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size YoY (2019-2030) & (US$ Million)
  • Figure 33. China Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Share by Type (2019-2030)
  • Figure 34. China Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Share by Application (2019-2030)
  • Figure 35. Asia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size YoY (2019-2030) & (US$ Million)
  • Figure 36. Asia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Share by Type (2019-2030)
  • Figure 37. Asia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Share by Application (2019-2030)
  • Figure 38. Asia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Share by Region (2019-2030)
  • Figure 39. Japan Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 40. South Korea Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 41. China Taiwan Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 42. Southeast Asia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 43. India Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 44. Australia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 45. Middle East, Africa, and Latin America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size YoY (2019-2030) & (US$ Million)
  • Figure 46. Middle East, Africa, and Latin America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Share by Type (2019-2030)
  • Figure 47. Middle East, Africa, and Latin America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Share by Application (2019-2030)
  • Figure 48. Middle East, Africa, and Latin America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Share by Country (2019-2030)
  • Figure 49. Brazil Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 50. Mexico Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 51. Turkey Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 52. Saudi Arabia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 53. Israel Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 54. GCC Countries Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 55. Roche Revenue Growth Rate in Neuromyelitis Optica Spectrum Disorders (NMOSD) Business (2019-2024)
  • Figure 56. Pfizer Revenue Growth Rate in Neuromyelitis Optica Spectrum Disorders (NMOSD) Business (2019-2024)
  • Figure 57. Fresenius Revenue Growth Rate in Neuromyelitis Optica Spectrum Disorders (NMOSD) Business (2019-2024)
  • Figure 58. Teva Revenue Growth Rate in Neuromyelitis Optica Spectrum Disorders (NMOSD) Business (2019-2024)
  • Figure 59. Sandoz Revenue Growth Rate in Neuromyelitis Optica Spectrum Disorders (NMOSD) Business (2019-2024)
  • Figure 60. Intas Revenue Growth Rate in Neuromyelitis Optica Spectrum Disorders (NMOSD) Business (2019-2024)
  • Figure 61. Nang Kuang Pharmaceutical Revenue Growth Rate in Neuromyelitis Optica Spectrum Disorders (NMOSD) Business (2019-2024)
  • Figure 62. Tianjin King York Revenue Growth Rate in Neuromyelitis Optica Spectrum Disorders (NMOSD) Business (2019-2024)
  • Figure 63. Baxter Revenue Growth Rate in Neuromyelitis Optica Spectrum Disorders (NMOSD) Business (2019-2024)
  • Figure 64. CSL Revenue Growth Rate in Neuromyelitis Optica Spectrum Disorders (NMOSD) Business (2019-2024)
  • Figure 65. Grifols Revenue Growth Rate in Neuromyelitis Optica Spectrum Disorders (NMOSD) Business (2019-2024)
  • Figure 66. Octapharma Revenue Growth Rate in Neuromyelitis Optica Spectrum Disorders (NMOSD) Business (2019-2024)
  • Figure 67. Bottom-up and Top-down Approaches for This Report
  • Figure 68. Data Triangulation
  • Figure 69. Key Executives Interviewed
目次

This research report focuses on the Neuromyelitis Optica Spectrum Disorders (NMOSD) Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
    • 1.2.2 Relapsing Form
    • 1.2.3 Monophasic Form
  • 1.3 Market by Application
    • 1.3.1 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
    • 1.3.2 Hospital
    • 1.3.3 Clinic
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Perspective (2019-2030)
  • 2.2 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Growth Trends by Region
    • 2.2.1 Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Region: 2019 VS 2023 VS 2030
    • 2.2.2 Neuromyelitis Optica Spectrum Disorders (NMOSD) Historic Market Size by Region (2019-2024)
    • 2.2.3 Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecasted Market Size by Region (2025-2030)
  • 2.3 Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Dynamics
    • 2.3.1 Neuromyelitis Optica Spectrum Disorders (NMOSD) Industry Trends
    • 2.3.2 Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Drivers
    • 2.3.3 Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Challenges
    • 2.3.4 Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Revenue Neuromyelitis Optica Spectrum Disorders (NMOSD) by Players
    • 3.1.1 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue by Players (2019-2024)
    • 3.1.2 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue Market Share by Players (2019-2024)
  • 3.2 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of Neuromyelitis Optica Spectrum Disorders (NMOSD), Ranking by Revenue, 2022 VS 2023 VS 2024
  • 3.4 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Concentration Ratio
    • 3.4.1 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Neuromyelitis Optica Spectrum Disorders (NMOSD) Revenue in 2023
  • 3.5 Global Key Players of Neuromyelitis Optica Spectrum Disorders (NMOSD) Head office and Area Served
  • 3.6 Global Key Players of Neuromyelitis Optica Spectrum Disorders (NMOSD), Product and Application
  • 3.7 Global Key Players of Neuromyelitis Optica Spectrum Disorders (NMOSD), Date of Enter into This Industry
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Neuromyelitis Optica Spectrum Disorders (NMOSD) Breakdown Data by Type

  • 4.1 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Historic Market Size by Type (2019-2024)
  • 4.2 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecasted Market Size by Type (2025-2030)

5 Neuromyelitis Optica Spectrum Disorders (NMOSD) Breakdown Data by Application

  • 5.1 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Historic Market Size by Application (2019-2024)
  • 5.2 Global Neuromyelitis Optica Spectrum Disorders (NMOSD) Forecasted Market Size by Application (2025-2030)

6 North America

  • 6.1 North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size (2019-2030)
  • 6.2 North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type
    • 6.2.1 North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2019-2024)
    • 6.2.2 North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2025-2030)
    • 6.2.3 North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Share by Type (2019-2030)
  • 6.3 North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application
    • 6.3.1 North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2019-2024)
    • 6.3.2 North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2025-2030)
    • 6.3.3 North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Share by Application (2019-2030)
  • 6.4 North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Country
    • 6.4.1 North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Country: 2019 VS 2023 VS 2030
    • 6.4.2 North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Country (2019-2024)
    • 6.4.3 North America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Country (2025-2030)
    • 6.4.4 United States
    • 6.4.5 Canada

7 Europe

  • 7.1 Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size (2019-2030)
  • 7.2 Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type
    • 7.2.1 Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2019-2024)
    • 7.2.2 Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2025-2030)
    • 7.2.3 Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Share by Type (2019-2030)
  • 7.3 Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application
    • 7.3.1 Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2019-2024)
    • 7.3.2 Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2025-2030)
    • 7.3.3 Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Share by Application (2019-2030)
  • 7.4 Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Country
    • 7.4.1 Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Country: 2019 VS 2023 VS 2030
    • 7.4.2 Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Country (2019-2024)
    • 7.4.3 Europe Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Country (2025-2030)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 China

  • 8.1 China Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size (2019-2030)
  • 8.2 China Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type
    • 8.2.1 China Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2019-2024)
    • 8.2.2 China Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2025-2030)
    • 8.2.3 China Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Share by Type (2019-2030)
  • 8.3 China Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application
    • 8.3.1 China Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2019-2024)
    • 8.3.2 China Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2025-2030)
    • 8.3.3 China Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Share by Application (2019-2030)

9 Asia (excluding China)

  • 9.1 Asia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size (2019-2030)
  • 9.2 Asia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type
    • 9.2.1 Asia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2019-2024)
    • 9.2.2 Asia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2025-2030)
    • 9.2.3 Asia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Share by Type (2019-2030)
  • 9.3 Asia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application
    • 9.3.1 Asia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2019-2024)
    • 9.3.2 Asia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2025-2030)
    • 9.3.3 Asia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Share by Application (2019-2030)
  • 9.4 Asia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Region
    • 9.4.1 Asia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Region: 2019 VS 2023 VS 2030
    • 9.4.2 Asia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Region (2019-2024)
    • 9.4.3 Asia Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Region (2025-2030)
    • 9.4.4 Japan
    • 9.4.5 South Korea
    • 9.4.6 China Taiwan
    • 9.4.7 Southeast Asia
    • 9.4.8 India
    • 9.4.9 Australia

10 Middle East, Africa, and Latin America

  • 10.1 Middle East, Africa, and Latin America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size (2019-2030)
  • 10.2 Middle East, Africa, and Latin America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type
    • 10.2.1 Middle East, Africa, and Latin America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2019-2024)
    • 10.2.2 Middle East, Africa, and Latin America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Type (2025-2030)
    • 10.2.3 Middle East, Africa, and Latin America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Share by Type (2019-2030)
  • 10.3 Middle East, Africa, and Latin America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application
    • 10.3.1 Middle East, Africa, and Latin America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2019-2024)
    • 10.3.2 Middle East, Africa, and Latin America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Application (2025-2030)
    • 10.3.3 Middle East, Africa, and Latin America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Share by Application (2019-2030)
  • 10.4 Middle East, Africa, and Latin America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Country
    • 10.4.1 Middle East, Africa, and Latin America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Country: 2019 VS 2023 VS 2030
    • 10.4.2 Middle East, Africa, and Latin America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Country (2019-2024)
    • 10.4.3 Middle East, Africa, and Latin America Neuromyelitis Optica Spectrum Disorders (NMOSD) Market Size by Country (2025-2030)
    • 10.4.4 Brazil
    • 10.4.5 Mexico
    • 10.4.6 Turkey
    • 10.4.7 Saudi Arabia
    • 10.4.8 Israel
    • 10.4.9 GCC Countries

11 Key Players Profiles

  • 11.1 Roche
    • 11.1.1 Roche Company Details
    • 11.1.2 Roche Business Overview
    • 11.1.3 Roche Neuromyelitis Optica Spectrum Disorders (NMOSD) Introduction
    • 11.1.4 Roche Revenue in Neuromyelitis Optica Spectrum Disorders (NMOSD) Business (2019-2024)
    • 11.1.5 Roche Recent Developments
  • 11.2 Pfizer
    • 11.2.1 Pfizer Company Details
    • 11.2.2 Pfizer Business Overview
    • 11.2.3 Pfizer Neuromyelitis Optica Spectrum Disorders (NMOSD) Introduction
    • 11.2.4 Pfizer Revenue in Neuromyelitis Optica Spectrum Disorders (NMOSD) Business (2019-2024)
    • 11.2.5 Pfizer Recent Developments
  • 11.3 Fresenius
    • 11.3.1 Fresenius Company Details
    • 11.3.2 Fresenius Business Overview
    • 11.3.3 Fresenius Neuromyelitis Optica Spectrum Disorders (NMOSD) Introduction
    • 11.3.4 Fresenius Revenue in Neuromyelitis Optica Spectrum Disorders (NMOSD) Business (2019-2024)
    • 11.3.5 Fresenius Recent Developments
  • 11.4 Teva
    • 11.4.1 Teva Company Details
    • 11.4.2 Teva Business Overview
    • 11.4.3 Teva Neuromyelitis Optica Spectrum Disorders (NMOSD) Introduction
    • 11.4.4 Teva Revenue in Neuromyelitis Optica Spectrum Disorders (NMOSD) Business (2019-2024)
    • 11.4.5 Teva Recent Developments
  • 11.5 Sandoz
    • 11.5.1 Sandoz Company Details
    • 11.5.2 Sandoz Business Overview
    • 11.5.3 Sandoz Neuromyelitis Optica Spectrum Disorders (NMOSD) Introduction
    • 11.5.4 Sandoz Revenue in Neuromyelitis Optica Spectrum Disorders (NMOSD) Business (2019-2024)
    • 11.5.5 Sandoz Recent Developments
  • 11.6 Intas
    • 11.6.1 Intas Company Details
    • 11.6.2 Intas Business Overview
    • 11.6.3 Intas Neuromyelitis Optica Spectrum Disorders (NMOSD) Introduction
    • 11.6.4 Intas Revenue in Neuromyelitis Optica Spectrum Disorders (NMOSD) Business (2019-2024)
    • 11.6.5 Intas Recent Developments
  • 11.7 Nang Kuang Pharmaceutical
    • 11.7.1 Nang Kuang Pharmaceutical Company Details
    • 11.7.2 Nang Kuang Pharmaceutical Business Overview
    • 11.7.3 Nang Kuang Pharmaceutical Neuromyelitis Optica Spectrum Disorders (NMOSD) Introduction
    • 11.7.4 Nang Kuang Pharmaceutical Revenue in Neuromyelitis Optica Spectrum Disorders (NMOSD) Business (2019-2024)
    • 11.7.5 Nang Kuang Pharmaceutical Recent Developments
  • 11.8 Tianjin King York
    • 11.8.1 Tianjin King York Company Details
    • 11.8.2 Tianjin King York Business Overview
    • 11.8.3 Tianjin King York Neuromyelitis Optica Spectrum Disorders (NMOSD) Introduction
    • 11.8.4 Tianjin King York Revenue in Neuromyelitis Optica Spectrum Disorders (NMOSD) Business (2019-2024)
    • 11.8.5 Tianjin King York Recent Developments
  • 11.9 Baxter
    • 11.9.1 Baxter Company Details
    • 11.9.2 Baxter Business Overview
    • 11.9.3 Baxter Neuromyelitis Optica Spectrum Disorders (NMOSD) Introduction
    • 11.9.4 Baxter Revenue in Neuromyelitis Optica Spectrum Disorders (NMOSD) Business (2019-2024)
    • 11.9.5 Baxter Recent Developments
  • 11.10 CSL
    • 11.10.1 CSL Company Details
    • 11.10.2 CSL Business Overview
    • 11.10.3 CSL Neuromyelitis Optica Spectrum Disorders (NMOSD) Introduction
    • 11.10.4 CSL Revenue in Neuromyelitis Optica Spectrum Disorders (NMOSD) Business (2019-2024)
    • 11.10.5 CSL Recent Developments
  • 11.11 Grifols
    • 11.11.1 Grifols Company Details
    • 11.11.2 Grifols Business Overview
    • 11.11.3 Grifols Neuromyelitis Optica Spectrum Disorders (NMOSD) Introduction
    • 11.11.4 Grifols Revenue in Neuromyelitis Optica Spectrum Disorders (NMOSD) Business (2019-2024)
    • 11.11.5 Grifols Recent Developments
  • 11.12 Octapharma
    • 11.12.1 Octapharma Company Details
    • 11.12.2 Octapharma Business Overview
    • 11.12.3 Octapharma Neuromyelitis Optica Spectrum Disorders (NMOSD) Introduction
    • 11.12.4 Octapharma Revenue in Neuromyelitis Optica Spectrum Disorders (NMOSD) Business (2019-2024)
    • 11.12.5 Octapharma Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Disclaimer
  • 13.3 Author Details